← Back to Search

Participants aged less than 14 years old for Type 1 Diabetes

N/A
Recruiting
Led By Remi Rabasa-Lhoret
Research Sponsored by Institut de Recherches Cliniques de Montreal
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Summary

A registry of individuals with type 1 diabetes open to all patients with type 1 diabetes living in Canada will be established. The objective of this registry will be to measure the frequency and the severity of episodes of hypoglycemia. Participants will be invited to answer questionnaires about the frequency of their hypoglycemic episodes, their fear about hypoglycemia, their symptoms of hypoglycemia, the factors in cause (insulin therapy, nutrition, exercise, etc.), etc. Participation to the registry is divided in 3 phases. The first phase is mandatory for all participants. Phases 2 and 3 are optional.

Eligible Conditions
  • Type 1 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of non-severe hypoglycemic episodes
Secondary outcome measures
Depression
Diabetes distress
Fear of hypoglycemia
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Participants aged less than 14 years oldExperimental Treatment2 Interventions
Group II: Participants aged 14 years old and olderExperimental Treatment9 Interventions

Find a Location

Who is running the clinical trial?

Institut de Recherches Cliniques de MontrealLead Sponsor
70 Previous Clinical Trials
4,368 Total Patients Enrolled
Remi Rabasa-LhoretPrincipal InvestigatorInstitut de recherches cliniques de Montréal
9 Previous Clinical Trials
225 Total Patients Enrolled
~1271 spots leftby Mar 2026